GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (WBO:EWLS) » Definitions » EV-to-FCF

Edwards Lifesciences (WBO:EWLS) EV-to-FCF : 83.16 (As of Apr. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Edwards Lifesciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Edwards Lifesciences's Enterprise Value is €48,947 Mil. Edwards Lifesciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was €589 Mil. Therefore, Edwards Lifesciences's EV-to-FCF for today is 83.16.

The historical rank and industry rank for Edwards Lifesciences's EV-to-FCF or its related term are showing as below:

WBO:EWLS' s EV-to-FCF Range Over the Past 10 Years
Min: 7.59   Med: 46.35   Max: 90.75
Current: 83.22

During the past 13 years, the highest EV-to-FCF of Edwards Lifesciences was 90.75. The lowest was 7.59. And the median was 46.35.

WBO:EWLS's EV-to-FCF is ranked worse than
81.18% of 372 companies
in the Medical Devices & Instruments industry
Industry Median: 25.71 vs WBO:EWLS: 83.22

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-25), Edwards Lifesciences's stock price is €82.64. Edwards Lifesciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €2.134. Therefore, Edwards Lifesciences's PE Ratio for today is 38.73.


Edwards Lifesciences EV-to-FCF Historical Data

The historical data trend for Edwards Lifesciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences EV-to-FCF Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.00 86.94 57.10 47.05 71.41

Edwards Lifesciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.05 50.39 82.98 51.91 71.41

Competitive Comparison of Edwards Lifesciences's EV-to-FCF

For the Medical Devices subindustry, Edwards Lifesciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's EV-to-FCF falls into.



Edwards Lifesciences EV-to-FCF Calculation

Edwards Lifesciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=48947.124/588.584
=83.16

Edwards Lifesciences's current Enterprise Value is €48,947 Mil.
Edwards Lifesciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €589 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edwards Lifesciences  (WBO:EWLS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Edwards Lifesciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=82.64/2.134
=38.73

Edwards Lifesciences's share price for today is €82.64.
Edwards Lifesciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.134.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Edwards Lifesciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (WBO:EWLS) Business Description

Traded in Other Exchanges
Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (WBO:EWLS) Headlines

No Headlines